Liposomal drug formulations for treatment of hematological malignancies
Expert Opin Pharmacother
.
2023 Sep-Dec;24(18):1911-1914.
doi: 10.1080/14656566.2023.2269086.
Epub 2024 Jan 5.
Authors
Daniel Cacic Limi
1
,
Håkon Reikvam
2
3
Affiliations
1
Department of Hematology and Oncology, Stavanger University Hospital, Stavanger, Norway.
2
Department of Clinical Science, University of Bergen, Bergen, Norway.
3
Department of Medicine, Haukeland University Hospital, Bergen, Norway.
PMID:
37823599
DOI:
10.1080/14656566.2023.2269086
No abstract available
Keywords:
Anthracyclines; Hematological malignancies; Liposomal drug formulation; Targeted therapy.
Publication types
Editorial
MeSH terms
Doxorubicin
Drug Compounding
Hematologic Neoplasms* / drug therapy
Humans
Liposomes*
Substances
Liposomes
Doxorubicin